RMRichard Makurumidze

Richard Makurumidze

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Richard Makurumidze has a total of 99 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A baseline cross-sectional survey of women’s and household-level health indicators in Tsakare Community, Mount Darwin District, Zimbabwe: findings to inform targeted public health interventions

    by Richard Makurumidze, Sibusiso Jokomo, Shuvai Chikombe, Memory Chimsimbe, Pamela Gorejena, Reason Tizora, Jayjay Karumazondo, Joseph Nyakuchena, Tinashe Mangena, George Mapiye, et al.

    Understanding the general health status of a community is paramount for informing effective public health interventions and policy decisions [1]. As part of the University of Zimbabwe Education 5.0...

  • Open Access

    The multi-mechanism pathway: quantifying the mediating role of perceived barriers of healthcare access in the relationship between intimate partner violence and antenatal care adherence across 31 sub-Saharan African countries

    by Shuyi Wang, Maryam Zaid, Mayassa Ally, Bruno Sunguya, Dominic Nkhoma, Richard Makurumidze, Felistar Mwakasungura, Jiayan Huang

  • Open Access

    Community Health and Demographic Surveillance System for Noncommunicable Disease Epidemiology Among Adults in Rural and Urban Zimbabwe, 2024-2029: Protocol for a Longitudinal Surveillance Study

    by Richard Makurumidze, Terrence Rudado Musekiwa, Justice Mudavanhu, Newten Handireketi, Manes Munyanyi, Cremance Tshuma, Marvellous Mhloyi, Justen Manasa, Jonathan Arthur Matenga, Simbarashe Rusakaniko

    Background: Zimbabwe currently faces a rapidly escalating burden of noncommunicable diseases (NCDs) concurrently with persistent communicable disease challenges, resulting in profound epidemiological differences between rural and urban populations. To effectively address this evolving epidemiological landscape and guide evidence-based public health interventions, reliable and high-quality longitudinal data are essential for capturing temporal shifts and contextual determinants often overlooked by conventional health information systems. Objective: This protocol details the methodology for establishing a health and demographic surveillance system (HDSS), a longitudinal, population-based cohort designed to continuously monitor the prevalence, incidence, and key determinants of NCDs, specifically cardiovascular diseases and diabetes, and their associated risk factors in selected rural (Mt Darwin) and urban (Bindura) sites in Mashonaland Central Province over a 5-year period (2024‐2029). Methods: The HDSS uses a stratified multistage sampling design to recruit adults (aged ≥18 y) residing across 2 rural and 2 urban wards. Initial activities include comprehensive community profiling and household mapping, followed by a rigorous baseline survey, with systematic follow-ups scheduled every year. Data encompass essential domains such as vital events, migration patterns, detailed social determinants of health, health behaviors, self-reported and clinically assessed NCDs, physical examinations (including height, weight, blood pressure, and waist/hip circumference), biochemical markers (fasting glucose, lipid profiles, and urine sodium/creatinine), and standardized verbal autopsies. Data capture will make use of REDCap (Research Electronic Data Capture) to facilitate real-time data entry and validation. The protocol is underpinned by rigorous quality assurance procedures, continuous community engagement, and comprehensive ethical oversight. Results: The Zimbabwe HDSS received ethical approval on July 30, 2024 (MRCZ/A/3191). Baseline data collection was completed in Mt Darwin (rural site) in December 2024 and in Bindura (urban site) in March 2025. Statistical analysis of baseline NCD prevalence, risk factor distributions, and rural-urban comparisons is underway, with findings expected to be submitted for publication by the end of 2026. The first annual longitudinal follow-up round is planned for the second quarter of 2027, subject to funding availability, with subsequent rounds scheduled annually through 2029. Longitudinal incidence estimates and NCD trend analyses are expected to be published progressively from 2026 to 2029. Conclusions: This community HDSS addresses a critical evidence deficit within Zimbabwe’s national health information infrastructure. By implementing an ethical, sustainable, and community-engaged research methodology, the HDSS serves as a potent regional model. It is designed to generate actionable, policy-relevant data for national health authorities and stakeholders, thereby accelerating the country’s NCD prevention and control agenda while simultaneously acting as an enduring platform for academic innovation, capacity building, and policy translation efforts targeting both rural and urban health disparities.

  • Open Access

    Understanding drivers of neonatal mortality in Zimbabwe: A machine learning approach using survey data

    by Absolom Mbinda, Rornald Muhumuza Kananura, Arsene Brunelle Sandie, Richard Makurumidze, Agbessi Amouzou

    In Zimbabwe, the neonatal mortality rate (NMR) is higher than the regional average, and the country is not on track to reach the Sustainable Development Goal of reducing the NMR by 2030. While other child mortality indicators have improved, NMR has increased. Using machine learning, we aimed to identify the key predictors of neonatal mortality in Zimbabwe. Pooled secondary data analysis of three rounds of the Zimbabwe Demographic Health Survey (ZDHS) from 2005 to 2015 was done. The study population was all the live births born to women aged 15–49 years within the 5 years prior to each round of the survey (n = 16,941). Multiple supervised binary classification machine learning models were built to predict neonatal death based on socio-economic, mother’s demographic, prenatal, delivery, and neonatal characteristics available in ZDHS. Sensitivity and area under the receiver operating curve (AUC ROC) were used to select the best model for the prediction of neonatal mortality. The best model was used to identify relatively important variables, and logistic regression was used to assess the magnitude and direction of effect. The eXtreme Gradient Boosting Model outperformed other models with a sensitivity of 0.74. Early breastfeeding initiation, birth weight, household size, and newborn post-natal care (PNC) were identified as the top predictors of neonatal mortality. Logistic regression revealed that lower birth weight (aOR [95%CI]: 0.9997 [0.9995 – 0.9999]) was positively associated with odds of neonatal mortality, while household size (aOR [95%CI]: 0.84 [0.80 – 0.89]), early breastfeeding initiation, aOR (0.28 [95%CI]: [0.21 – 0.37]) and newborn postnatal care, (aOR [95%CI]: 0.08 [0.06 – 0.11]) were negatively associated with the odds of neonatal mortality. This study demonstrates the potential of machine learning in identifying key predictors of neonatal mortality in Zimbabwe. To accelerate the reduction in neonatal mortality, interventions should focus on preventing and specially managing low birth weight babies to improve survival. Furthermore, health facilities and community-level support for early initiation of breastfeeding and PNC checks should be promoted for all eligible newborns.


  • Open Access

    Self-discontinuation of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women in Mazowe District, Zimbabwe

    by Godwin Choga, Owen Mugurungi, Gerald Shambira, Addmore Chadambuka, Tsitsi Patience Juru, Notion Tafara Gombe, Mufuta Tshimanga, Richard Makurumidze

    Background: Adolescent girls and young women (AGYW) in Zimbabwe are at high risk of acquiring HIV. In 2020, HIV incidence among AGYW was 9.5 times that of males. AGYW are targeted for Pre-Exposure Prophylaxis (PrEP). In Mazowe District, 28.7% of AGYW who were initiated on PrEP in 2021 self-discontinued within a month. This limits the effectiveness of PrEP and increases the risk of HIV drug resistance. We determined factors associated with PrEP self-discontinuation among AGYW in Mazowe. Methods: We conducted an analytical cross-sectional study among HIV-negative AGYW initiated on PrEP. Participants were randomly selected proportionate to number initiated on PrEP in 20 health facilities in Mazowe District. Using Interviewer-administered questionnaires, data was collected on sexual behaviour, reasons for starting PrEP, and determinants of self-discontinuation. We performed logistic regression analysis at 5% significance-level to determine independent factors for PrEP self-discontinuation using Epi Info 7.2. Results: Of the 384 AGYW included in the study, 57.8% were married, 24.5% were divorced, and 17.7% were never married. Commonly reported reasons for starting PrEP were multiple sexual partners (29.2%) and promiscuous sexual partners (29.2%). The proportion of PrEP self-discontinuation was 41% with a median time to self-discontinuation of 4 (IQR 2-5) months. Of 157 AGYW who self-discontinued PrEP, 59.2% had multiple sexual partners, and 57.3% had transactional sex after discontinuing PrEP. Independent factors associated with PrEP self-discontinuation among AGYW were being a sex worker [aOR 4.86; 95% CI (1.33-17.69)], non-disclosure of PrEP status to sexual partner [aOR 3.63; 95% CI (2.13-6.19)], being discouraged to take PrEP by sexual partner [aOR 3.04; 95% CI (1.31-7.04)] and experiencing PrEP side effects [aOR 2.38; 95% CI (1.49-3.81)]. Conclusions: Being a sex worker, lack of partner support, and PrEP side effects were significant risk factors for self-discontinuation of PrEP. Improved, differentiated PrEP services’ provision and investing in community awareness may enhance PrEP retention.


  • Top Cited Papers
    Open Access

    A decade of designing and implementing electronic health records in Sub-Saharan Africa: a scoping review

    by Hamufare Dumisani Mugauri, Memory Chimsimbe, Gerald Shambira, Shepherd Shamhu, Juliet Nyamasve, Manes Munyanyi, Robert Gongora, Simukai Zizhou, Meggie Gabida, Richard Makurumidze

    Electronic Health Records (EHR) systems offer extensive opportunities to enhance healthcare delivery in sub-Saharan African (SSA) countries by improving data management and patient care and reducing errors. Nonetheless, EHR systems face a myriad of challenges, ranging from infrastructure and resources to policy, data management, and implementers' capacitation. This review provides a comprehensive 10-year overview of EHR implementation in the SSA region. A systematic search of PubMed, Web of Science and HINARI databases identified 30 relevant studies published from 2014 to 2024. Inclusion criteria focused on studies discussing the implementation, benefits, and challenges of EHR systems in SSA countries. Data extraction and thematic analysis facilitated the synthesis of findings. The review identified themes organized into four categories: EHR-enabled data management reduced errors, enhanced accuracy, and improved accessibility of patient records. Improved patient care correlated with better data management, facilitating timely and informed decision-making. Challenges such as limited infrastructure (power and connectivity), financial constraints, data privacy concerns, and the need for extensive training were prevalent. User acceptance also emerged as a critical barrier, with healthcare providers often resistant to adopting innovative technologies due to perceived complexity and the time required for training. EHR systems can significantly enhance healthcare delivery in sub-Saharan Africa. To fully realize these benefits, it is crucial to address challenges through targeted strategies and investments. By investing in reliable infrastructure, securing financial support, enhancing data security, developing comprehensive training programmes, and engaging stakeholders, sub-Saharan Africa can improve data management, patient care, and overall healthcare outcomes.


  • Open Access

    Gaps and recommendations on the management of the coronavirus disease 2019 (COVID-19) in the Zimbabwean quarantine centres during the first wave (March - October 2020)

    by Richard Makurumidze, Mutsa Mhangara, Justice Mudavanhu, Grant Murewanhema

    The cases of coronavirus disease 2019 (COVID-19) in Zimbabwe increased substantially between the 26th of May 2020 and the 12th of June 2020 from 56 to 343 (513%), and 95% of these cases were detected from the returning residents (returnees) in the quarantine centres. There was a debate on the source of infection among the returnees. We conducted a narrative review using secondary data from the media, government and other stakeholders to understand the conditions in the quarantine centres. Conditions that predisposed the returnees to acquire COVID-19 in the quarantine centres included over-crowding; lack of appropriate COVID-19 screening tests; sub-optimal follow-up and monitoring of clients; lack of personal protective equipment; low staffing; non-adherence to policies and guidelines; inadequate supervision and security; weak monitoring and evaluation systems. The findings showed that the returnees were at increased risk of getting COVID-19 infection in the quarantine centres because of the poor living conditions, sub-optimal follow-up and supervision. The government and stakeholders should continually address the gaps in quarantine centres since they can be a potential source of initiating community transmission.

  • Open Access

    Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018

    by Trudy Tholakele Mhlanga, Bart K. M. Jacobs, Tom Decroo, Emma Govere, Hilda Bara, Prosper Chonzi, Ngwarai Sithole, Tsitsi Apollo, Wim Van Damme, Simbarashe Rusakaniko, et al.

    Background: Since the scale-up of routine viral load (VL) testing started in 2016, there is limited evidence on VL suppression rates under programmatic settings and groups at risk of non-suppression. We conducted a study to estimate VL non-suppression (> 1000 copies/ml) and its risk factors using "routine" and "repeat after enhanced adherence counselling (EAC)" VL results.Methods: We conducted an analytic cross-sectional study using secondary VL testing data collected between 2014 and 2018 from a centrally located laboratory. We analysed data from routine tests and repeat tests after an individual received EAC. Our outcome was viral load non-suppression. Bivariable and multivariable logistic regression was performed to identify factors associated with having VL non-suppression for routine and repeat VL.Results: We analysed 103,609 VL test results (101,725 routine and 1884 repeat test results) collected from the country’s ten provinces. Of the 101,725 routine and 1884 repeat VL tests, 13.8% and 52.9% were non-suppressed, respectively. Only one in seven (1:7) of the non-suppressed routine VL tests had a repeat test after EAC. For routine VL tests; males (vs females, adjusted odds ratio (aOR) = 1.19, [95% CI 1.14–1.24]) and adolescents (10–19 years) (vs adults (25–49 years), aOR = 3.11, [95% CI 2.9–3.31]) were more at risk of VL non-suppression. The patients who received care at the secondary level (vs primary, aOR = 1.21, [95% CI 1.17–1.26]) and tertiary level (vs primary, aOR = 1.63, [95% CI 1.44–1.85]) had a higher risk of VL non-suppression compared to the primary level. Those that started ART in 2014–2015 (vs < 2010, aOR = 0.83, [95% CI 0.79–0.88]) and from 2016 onwards (vs < 2010, aOR = 0.84, [95% CI 0.79–0.89]) had a lower risk of VL non-suppression. For repeat VL tests; young adults (20–24 years) (vs adults (25–49 years), (aOR) = 3.48, [95% CI 2.16 -5.83]), adolescents (10–19 years) (vs adults (25–49 years), aOR = 2.76, [95% CI 2.11–3.72]) and children (0–9 years) (vs adults (25–49 years), aOR = 1.51, [95% CI 1.03–2.22]) were at risk of VL non-suppression.Conclusion: Close to 90% suppression in routine VL shows that Zimbabwe is on track to reach the third UNAIDS target. Strategies to improve the identification of clients with high routine VL results for repeating testing after EAC and ART adherence in subpopulations (men, adolescents and young adolescents) at risk of viral non-suppression should be prioritised.


  • Open Access

    Assessment of COVID-19 vaccine hesitancy among Zimbabweans: A rapid national survey

    by Paddington Tinashe Mundagowa, Samantha Nokuthula Tozivepi, Edward Tafumaneyi Chiyaka, Fadzai Mukora-Mutseyekwa, Richard Makurumidze

    Background: As a way of minimising the devastating effects of the coronavirus disease 2019 (COVID-19) pandemic, scientists hastily developed a vaccine. However, the scale-up of the vaccine is likely to be hindered by the widespread social media misinformation. We therefore conducted a study to assess the COVID-19 vaccine hesitancy among Zimbabweans. Methods: We conducted a descriptive online cross-sectional survey using a self-administered questionnaire among adults. The questionnaire assessed willingness to be vaccinated; socio-demographic characteristics, individual attitudes and perceptions, effectiveness and safety of the vaccine. Multivariable logistic regression analysis was utilized to examine the independent factors associated with vaccine uptake. Results: We analysed data for 1168 participants, age range of 19–89 years with the majority being females (57.5%). Half (49.9%) of the participants reported that they would accept the COVID-19 vaccine. Majority were uncertain about the effectiveness of the vaccine (76.0%) and its safety (55.0%). About half lacked trust in the government’s ability to ensure availability of an effective vaccine and 61.0% mentioned that they would seek advice from a healthcare worker to vaccinate. Chronic disease [vs no chronic disease—Adjusted Odds Ratio (AOR): 1.50, 95% Confidence Interval (CI)I: 1.10–2.03], males [vs females—AOR: 1.83, 95%CI: 1.37–2.44] and being a healthcare worker [vs not being a health worker—AOR: 1.59, 95%CI: 1.18–2.14] were associated with increased likelihood to vaccinate. Conclusion: We found half of the participants willing to vaccinate against COVID-19. The majority lacked trust in the government and were uncertain about vaccine effectiveness and safety. The policy makers should consider targeting geographical and demographic groups which were unlikely to vaccinate with vaccine information, education and communication to improve uptake.


  • Open Access

    Virological Outcomes and Risk Factors for Non-suppression for Routine and Repeat Viral Load Testing After Enhanced Adherence Counselling During Viral Load Testing Scale-up in Zimbabwe: Analytic Cross-sectional Study Using Laboratory Data From 2014 to 2018.

    by Trudy Tholakele Mhlanga, Bart K.M Jacobs, Tom Decroo, Emma Govere, Hilda Bara, Prosper Chonzi, Ngwarai Sithole, Tsitsi Apollo, Wim Van Damme, Simbarashe Rusakaniko, et al.

    BackgroundSince the scale-up of routine viral load (VL) testing started in 2016, there is limited evidence on VL suppression rates under programmatic settings and groups at risk of non-suppression. We conducted a study to estimate VL non-suppression (> 1000 copies/ml) and its risk factors using "routine" and "repeat after enhanced adherence counselling" VL results.MethodsWe conducted an analytic cross-sectional study using secondary VL testing data collected between 2014 and 2018 from a centrally located laboratory. We analysed data from routine tests and repeat tests after an individual received enhanced adherence counselling. Our outcome was viral load non-suppression. Bivariable and multivariable logistic regression was performed to identify factors associated with having VL non-suppression for routine and repeat VL.ResultsWe analysed 103 609 VL test results (101 725 routine and 1884 repeat tests results) collected from the country's ten provinces. Of the 101 725 routine and 1884 repeat VL tests, 13.8% and 52.9% were non-suppressed, respectively. Only one in seven (1:7) of the non-suppressed routine VL tests had a repeat test after EAC. For routine VL tests; males (vs females, adjusted odds ratio (aOR)=1.19, [95% CI:1.14-1.24]) and adolescents (vs adults, aOR=3.11, [95%CI:2.9-3.31]) were more at risk of VL non-suppression. The patients who received care at the secondary level (vs primary, aOR=1.21, [95%CI:1.17-1.26]) and tertiary level (vs primary, aOR=1.63, [95%CI:1.44-1.85]) had a higher risk of VL non-suppression compared to the primary level. Those that started ART in 2014-2015 (vs <2010, aOR=0.83, [95%CI:0.79-0.88]) and from 2016 onwards (vs <2010, aOR=0.84, [95%CI:0.79-0.89]) had a lower risk of VL non-suppression. For repeat VL tests; young adults (vs adults, (aOR)=3.48, [95% CI 2.16 -5.83]), adolescents (vs adults, aOR=2.76, [95% CI:2.11-3.72]) and children (vs adults, aOR=1.51, [95%CI:1.03-2.22]) were at risk of VL non-suppression.ConclusionClose to 90% suppression in routine VL shows that Zimbabwe is on track to reach the third UNAIDS target. Strategies to improve the identification of clients with high routine VL results for repeating testing after EAC and ART adherence in subpopulations (men, adolescents and young adolescents) at risk of viral non-suppression should be prioritised.